more common [10, 11] and that extrapulmonary tuberculosis disease was less common in tuberculosis-HIV coinfected patients after HAART introduction, compared with such patients before HAART introduction [10] . However, another recent study found that cavitary lesions remained less common and extrapulmonary tuberculosis remained more common among HIV-infected tuberculosis patients, compared with the corresponding prevalences for HIV-uninfected tuberculosis patients in the United States [12] . In addition to the introduction of HAART, other changes in the United States during the past 15 years have likely affected the epidemiology of both diseases, including expanded recommendations for HIV screening and increases in HIV testing [13] , strengthening of tuberculosis control practices [14] , and increases in immigration [15] .
To facilitate effective diagnosis and treatment, it is important to understand the presentation of tuberculosis among HIVinfected persons in settings where access to HAART is widespread. To understand how changes in both the tuberculosis and HIV epidemics affect HIV-infected tuberculosis patients in NYC, we evaluated changes in the sociodemographic and clinical characteristics of HIV-infected tuberculosis patients from 1992 through 2005 and compared these with changes seen in HIV-uninfected tuberculosis patients.
MATERIALS AND METHODS
In NYC, health care providers and laboratories are required by law to report all suspected and confirmed tuberculosis cases to the Department of Health and Mental Hygiene (DOHMH); all reports are entered in the tuberculosis registry. The DOHMH tuberculosis staff interview all patients with confirmed cases, obtain clinical and treatment information, and provide case management until completion of treatment. Information obtained through these activities is entered in the tuberculosis registry. The present analysis included all tuberculosis cases verified by the NYC DOHMH, from 1 January 1992 through 31 December 2005, that had HIV status information recorded in the tuberculosis registry. HIV coinfection was defined as documentation of positive results for an enzyme-linked immunosorbent assay or a rapid HIV antibody test with confirmation by means of Western blot testing, or documentation of history of a positive HIV test result in the medical record. Tuberculosis patients were classified as HIV-uninfected if they had documentation of a negative result for an HIV test performed !1 year before tuberculosis diagnosis or during tuberculosis treatment.
A cross-match of tuberculosis patients who were recorded as HIV-infected in the tuberculosis registry was performed with the NYC HIV/AIDS Reporting System (HARS) to obtain information on AIDS diagnosis date and HIV risk factors. HIV surveillance staff first linked patients by tuberculosis registry number. If no match was found, a deterministic algorithm based on name, date of birth, and Social Security number was used to identify additional potential matches with patients in HARS. Two independent reviewers verified potential matches with additional variables as needed (eg, gender, race, and country of birth), with discordant decisions resolved by a third independent reviewer. The AIDS diagnosis date was obtained instead of the HIV diagnosis date, because HIV infection without AIDS was not reportable in New York State until June 2000. CD4+ T lymphocyte counts and HIV viral load were not available for this analysis. Patients with an unknown HIV status in the tuberculosis registry were excluded from all analyses. To determine how many tuberculosis patients were HIV-infected, HIV surveillance staff matched their records to HARS to determine the proportion who were recorded as an HIV/AIDS patient in HARS at the time of tuberculosis diagnosis. For confidentiality reasons, individual-level information on matched patients was not provided for the analysis.
Sociodemographic and clinical characteristics were obtained from the tuberculosis registry. For HIV-infected tuberculosis patients, HIV risk factor information and date of AIDS diagnosis were obtained from HARS. Because the probability of HIV transmission is much greater for injection drug use (IDU) than for men having sex with other men, HIV-infected men who reported both behaviors were classified as IDU; 208 (4%) of 5146 HIV-infected male tuberculosis patients reported both behaviors. Otherwise, when 11 risk factor was reported, persons were classified in accordance with the Centers for Disease Control and Prevention (CDC) hierarchy of transmission categories [16] . Because data on HAART use were unavailable, characteristics were examined across 3 periods on the basis of year of tuberculosis diagnosis: 1992-1995 (pre-HAART), 1996-2000 (early HAART), and 2001-2005 (late HAART). The dates for the periods were chosen because HAART became widely available in the United States and NYC in 1996 [17, 18] .
Temporal changes in sociodemographic and clinical characteristics were evaluated separately for HIV-infected and HIVuninfected tuberculosis patients with the Cochran-Armitage trend test (2-sided). To further assess the magnitude of these findings, changes in clinical characteristics were also evaluated, using multivariate logistic regression with study period as the outcome variable. Risk estimates were obtained using 2 separate models: (1) early HAART compared with pre-HAART and (2) late HAART compared with early HAART. All multivariate analyses were adjusted for age (!18, 18-44, 45-64, or у65 years), gender, race and/or ethnicity (non-Hispanic white, nonHispanic black, Asian, Hispanic, or other and/or unknown), and birth in the United States (yes, no, or unknown). The models for HIV-infected patients were also adjusted for years with AIDS before tuberculosis diagnosis (same year, 1-5 years, or 15 years) and for risk factor for HIV infection (history of IDU, heterosexual, men who had sex with men, other, or un- Extrapulmonary only 497 (12) 282 (15) 157 (18) !.001
407 (14) 807 (20) 680 (23) !.001
Pulmonary and extrapulmonary 884 (20) 528 (27) 238 (28) !.001
204 (7) 343 (9) 265 (9) .010
Site of any extrapulmonary tuberculosis Bone or joint 135 (10) 52 (7) 22 (6) .001 104 (17) 166 (14) 127 (13) .059
Miliary 66 (5) 121 (15) 34 (8) !.001
16 (3) 47 (4) 20 (2) .352
Peritoneal 32 (2) 23 (3) 9 (2) .809 21 (3) 47 (4) 42 (4) .334
Pleural 140 (10) 87 (11) 43 (11) .603 131 (21) 253 (22) 196 (21) .680
Meningeal 103 (8) 78 (10) 47 (12) .004 37 (6) 49 (4) 49 (5) .582
Genitourinary 104 (7) 53 (7) 14 (4) .008 50 (8) 84 (7) 53 (6) .042
Other 460 (33) 139 (17) 71 (18) !.001
81 (13) 104 (9) 82 (9) .006
Lung cavity among patients with pulmonary tuberculosis Yes 307 (9) 109 (7) 48 (8 2416 (84) 3197 (80) 2271 (77) !.001
Negative 314 (7) 271 (14) 182 (21) 463 (16) Not done 253 (6) 37 (2) 5 (1) !.001
87 (4) 55 (2) 21 (1) !.001
Died from any cause Yes, before tuberculosis treatment was initiated 541 (12) 166 (8) 64 (7) !.001
74 (2) 89 (2) 33 (1) !.001
Yes, during tuberculosis treatment 1244 (29) 287 (15) 91 (11) !.001
138 (5) 130 (3) known). All analyses were performed using SAS, version 9.1 (SAS Institute). This study was approved by the NYC DOHMH and CDC institutional review boards. All project-specific information was kept confidential and was available only to authorized staff who were trained in the protection of human subjects and confidentiality.
RESULTS
During 1992-2005, there were 25,704 tuberculosis cases verified in NYC. HIV status was recorded as positive or negative in the tuberculosis registry for 59% (4402 positive, 2879 negative, and 12,258 total) in the pre-HAART period, 74% (1952 positive, 3990 negative, and 7993 total) in the early HAART period, and 70% (872 positive, 2964 negative, and 5453 total) in the late HAART period. The analysis excluded 8645 tuberculosis patients with unknown HIV status; these patients were similar to HIV-uninfected patients with respect to gender, disease site, and smear, culture, chest radiograph, and drug susceptibility test results (data not shown). They were more likely than HIVuninfected patients to be у65 years of age, more likely to be foreign born, and less likely to be Hispanic. Records for patients with unknown HIV status in the tuberculosis registry were matched to HARS; 622 (7%) of 8645 patients were determined to be infected with HIV at the time of tuberculosis diagnosis, the majority (546 [88%] of 622 patients) from the pre-HAART period. These patients were excluded from all further analyses. There were 87 tuberculosis patients who were recorded as being HIV infected in the tuberculosis registry but who did not match anyone in HARS; 57 were from the pre-HAART, 9 from the early HAART, and 21 from the late HAART period. These patients were also excluded from all analyses. The final study population comprised 16,972 tuberculosis patients. We determined that 4345 (60%) of 7224 patients were HIV infected in the pre-HAART period; 1943 (33%) of 5933 patients were HIV infected in the early HAART period; and 851 (22%) of 3815 patients were HIV infected in the late HAART period (P ! for trend). Over time, the age of HIV-infected tuberculosis .001 patients increased and greater proportions were female, nonHispanic black, Asian, and foreign born ( Table 1 ). The proportion that was non-Hispanic white decreased. For HIV-uninfected tuberculosis patients, the proportions that were foreign born, Asian, and Hispanic increased over time; however, their age decreased. The proportions that were non-Hispanic white and non-Hispanic black decreased (Table 1) .
Over time, the proportion of HIV-infected tuberculosis patients who had extrapulmonary-only disease increased (from 12% to 18%) and who had both pulmonary and extrapulmonary disease increased (from 20% to 28%) (both, for trend; P ! .001 Table 1 ). Because extrapulmonary disease may be more common in foreign-born patients and immigration to the United States has increased, we examined whether this increase was found in both foreign-and US-born patients. The increase in extrapulmonary-only disease was significant only among US-born HIVinfected tuberculosis patients (from 11% to 17%; for P ! .001 trend), but the increase was seen in foreign-born patients also (from 17% to 20%; for trend). For disease that involved P p .140 both pulmonary and extrapulmonary sites, an increase was seen among the foreign-born (from 22% to 31%; for trend), P ! .001 and a small decrease was observed among the US-born (from 30% to 26%; for trend). Extrapulmonary tuberculosis P ! .001 also increased among HIV-uninfected tuberculosis patients, but in all periods, the proportion of HIV-uninfected patients with extrapulmonary disease was lower than the corresponding proportion of HIV-infected patients; this was especially true for concurrent pulmonary and extrapulmonary disease. The increase was not seen for all extrapulmonary sites of disease. Among HIVinfected patients, significant increases were seen for lymphatic and meningeal tuberculosis, whereas decreases were seen for bone or joint and genitourinary tuberculosis ( Table 1) .
The proportion of HIV-infected tuberculosis patients who were culture-negative for Mycobacterium tuberculosis (ie, not culture-confirmed) increased from 7% in the pre-HAART period to 21% in late HAART ( for trend; Table 1 ). The P ! .001 proportion with culture-negative tuberculosis increased for HIV-uninfected patients also, although the increase was smaller (from 16% to 23%; for trend). Among HIV-infected P ! .001 patients, the proportion with a sputum or other respiratory tract specimen that was acid-fast bacilli smear-positive decreased slightly between the first 2 periods (from 43% to 40%; ); findings were similar among HIV-uninfected pa-P p .015 tients. The proportion of HIV-infected tuberculosis patients who had a cavity detected on chest radiograph did not change ( ); however, the proportion with a cavity was consis-P p .411 tently less than the corresponding proportion of HIV-uninfected patients.
The proportion of patients with multidrug-resistant tuberculosis (isolate resistant to at least isoniazid and rifampin) decreased over time for HIV-infected (from 16% to 4%) and HIV-uninfected (from 7% to 3%) patients (both, for P ! .001 trend). There was no significant change in the proportion of patients with other drug resistance patterns. Over the study period, HIV-infected and HIV-uninfected tuberculosis patients had decreased mortality both before tuberculosis treatment was initiated and during the course of treatment (Table 1 and Figure  1) ; however, the decrease was much larger for HIV-infected patients, and they were much more likely to die than HIVuninfected patients, even during the late HAART period (18% in HIV-infected vs 3% in HIV-uninfected). Compared with the pre-HAART period, in the late HAART period HIV-infected tuberculosis patients had AIDS longer before tuberculosis diagnosis and their risk factors for HIV infection changed, with IDU decreasing and heterosexual transmission increasing (Table 1) .
We examined clinical findings from the bivariate analysis with multivariate logistic regression, controlling for age, race, gender, country of birth, years living with AIDS before tuberculosis, and risk factor for HIV infection ( Table 2 ). The models confirmed that among HIV-infected tuberculosis patients, extrapulmonaryonly disease (adjusted odds ratio [aOR], 1.35; 95% confidence interval [CI], 1.12-1.63) and the presence of both pulmonary and extrapulmonary disease (aOR, 1.79; 95% CI, 1.55-2.06) were significantly elevated in the early HAART period, compared with the pre-HAART period. Patients were also more likely to have extrapulmonary tuberculosis in the late HAART period, compared with the early HAART period; however, the association was not as strong. The model confirmed that HIV-infected tu- berculosis patients were more likely to have culture-negative disease in the early HAART versus in the pre-HAART period (aOR, 1.68; 95% CI, 1.38-2.04) and in the late HAART versus in the early HAART period (aOR, 1.42; 95% CI, 1.12-1.80). Patients were also more likely to have a positive respiratory acid-fast bacilli smear in the late HAART period than in the early HAART period. In the early HAART period compared with pre-HAART, HIV-infected tuberculosis patients experienced lower mortality before tuberculosis treatment was initiated (aOR, 0.51; 95% CI, 0.41-0.62) and during the course of treatment (aOR, 0.41; 95% CI, 0.35-0.47); only the latter was significant comparing the late and early HAART periods. In a model restricted to HIVinfected patients who were culture-positive for Mycobacterium tuberculosis, multidrug-resistant tuberculosis (aOR, 0.31; 95% CI, 0.25-0.40) and other-drug-resistant tuberculosis (aOR, 0.81; 95% CI, 0.67-0.98) were less common in the early HAART than in the pre-HAART period; there was no significant difference between the later periods. When the model was restricted to HIV-infected patients with pulmonary disease, there was no change in the presence of lung cavities (data not shown). Similar results for culture, smear, and site of disease were also seen for the HIV-uninfected tuberculosis patients; however, the risk estimates were not as large (Table 2) .
DISCUSSION
Between 1992 and 2005, we found significant changes in the sociodemographic and clinical characteristics for both HIVinfected and HIV-uninfected tuberculosis patients in NYC, including increases in the proportions with culture-negative tuberculosis and with extrapulmonary tuberculosis and decreases in the proportion with multidrug-resistant tuberculosis and that died. The magnitude of the changes was greater among HIV-infected persons and was especially pronounced when HAART became widely available.
The increase in the proportion of HIV-infected tuberculosis patients who were culture-negative was larger between the first 2 periods and, by late HAART, approached that in HIV-uninfected patients. Because the same trend was seen among HIV-uninfected tuberculosis patients, this increase may be explained by more physicians considering tuberculosis as a diagnosis when evaluating patients or by increased reporting of cases diagnosed by clinical findings without laboratory confirmation. In NYC a widely publicized "Think tuberculosis" campaign was conducted in the early 1990s.
The proportion of HIV-infected tuberculosis patients who had extrapulmonary tuberculosis also increased. This finding is somewhat surprising, because extrapulmonary disease is more common with increasing immunosuppression [4, 19, 20] , and we would expect immunosuppression among the HIVinfected population to decrease as HAART became available and widely used. Other studies report that the proportion of HIV-infected tuberculosis patients with extrapulmonary disease decreased after HAART introduction [10] . One explanation may be that, in earlier periods, many HIV-infected tuberculosis patients died before antituberculosis treatment was initiated and before complete evaluations to diagnose extrapulmonary tuberculosis could be performed. Also, in recent years, HIVinfected patients who develop tuberculosis may receive concurrent tuberculosis and HIV diagnoses and be more immunosuppressed (and less likely to be receiving HAART) than HIV-infected persons who do not develop tuberculosis. We were not able to examine this hypothesis, because we lacked information on HAART use, CD4 count, and HIV viral load. However, the observation that, even in the latest period, extrapulmonary tuberculosis and mortality were more common among HIV-infected patients than among HIV-uninfected patients supports this hypothesis. Furthermore, extrapulmonary tuberculosis is more common among foreign-born patients [21] , and because the proportion of tuberculosis patients that are foreign born has increased over time, this may explain the observed increase in extrapulmonary tuberculosis among both HIV-uninfected and HIV-infected tuberculosis patients in NYC and in the entire United States [12] . However, our finding that the increase in extrapulmonary-only disease was significant only among US-born HIV-infected tuberculosis patients may refute this hypothesis.
Also unexpected was the finding that the proportion of HIVinfected patients with pulmonary tuberculosis who had a lung cavity on their chest radiograph, a finding usually associated with less immunosuppression [3, 22, 23] , remained constant during the study period. A small increase (5.3%) in the proportion of HIV-infected pulmonary tuberculosis patients with a cavity was observed in the United States from 1993 to 2004 [12] and in other studies as well [10, 11] . However, HIV-infected persons in NYC who develop tuberculosis may be more immunosuppressed than HIV-infected persons in NYC who do not develop tuberculosis, and the proportion with a cavity was much smaller than the corresponding proportion in HIV-uninfected tuberculosis patients. As tuberculosis incidence decreases in the United States, it will be even more important that clinicians continue to consider tuberculosis when evaluating HIV-infected patients, especially those without pulmonary symptoms or with radiologic findings atypical for tuberculosis.
Our finding that multidrug-resistant tuberculosis has decreased among HIV-infected and HIV-uninfected tuberculosis patients is consistent with prior reports from NYC [1] and the entire United States [12] ; this likely reflects the increase in tuberculosis control activities in the 1990s, especially the implementation of directly observed therapy [14, 24] . The proportion of HIV-infected tuberculosis patients who died before antituberculosis treatment was initiated decreased, and the length of time between AIDS diagnosis and tuberculosis disease increased, both of which may reflect improvements in the immunity of HIV-infected persons due to HAART, increased awareness about HIV-tuberculosis comorbidity among clinicians, and better tuberculosis control practices [14, 17, 24] . However, mortality was significantly higher among HIV-infected tuberculosis patients, compared with mortality among HIV-uninfected tuberculosis patients.
This study has several limitations. HIV status was unknown for some tuberculosis patients in the tuberculosis registry, of whom 7% matched to HARS. However, tuberculosis patients with unknown HIV status were similar to HIV-uninfected patients with respect to most characteristics, making it unlikely that their exclusion biased our results. They were more likely than HIV-uninfected patients to be у65 years of age and foreign born and less likely to be Hispanic, which reflects HIV testing practices in NYC [25] . Another limitation is that certain information was unavailable for this analysis, including CD4+ T lymphocyte counts, HIV viral load, HAART use, and history of other comorbidities. We also could not include tuberculin skin test results and drug and/or alcohol use in the analysis because of large amounts of missing data (eg, 150% of HIVinfected patients had a missing tuberculin skin test result). In addition, because HIV infection did not become reportable in New York State until 2000, we did not include HIV diagnosis date in the analysis. Despite these limitations, we were able to detect several important changes in the characteristics of HIVinfected tuberculosis patients.
Although the severity of the HIV and tuberculosis epidemics has decreased in recent years, they remain important diseases from both a public health and a clinical perspective. The clinical presentation of tuberculosis has changed substantially in 14 years, with more pronounced changes observed in persons who are living with HIV infection. Awareness of these changes may help clinicians diagnose tuberculosis more promptly, especially in HIV-infected patients. Clinicians should continue to be alert for atypical presentations among HIV-infected patients and among patients who may be HIV-infected but who are unaware of their status. Prompt diagnosis of tuberculosis and initiation of treatment is especially important in HIV-infected patients, because they continue to experience higher mortality. Future studies should prospectively evaluate the risk of developing tuberculosis and its presentation among HIV-infected patients with well-managed HIV infection and those with poorly controlled disease.
